Autologous bone marrow mononuclear cell administration in a large cohort of 1,011 patients with autism spectrum disorder: a retrospective observational study
Intrathecal transplantation of autologous BMMNCs, combined with neurorehabilitation, yields positive outcomes for patients with ASD. This approach helps reduce the degree of impairment and improves quality of life.
Authors
- Hema Biju (ORCID: https://orcid.org/0009-0005-0385-5068)
- Zubiya Shaikh (ORCID: https://orcid.org/0009-0009-4772-2194)
- Amruta Paranjape (ORCID: https://orcid.org/0000-0003-2099-7648)
- Myola D’sa (ORCID: https://orcid.org/0009-0009-0186-6467)
- Nandini Gokulchandran (ORCID: https://orcid.org/0000-0003-2195-7015)
- Prerna Badhe (ORCID: https://orcid.org/0000-0002-5982-4704)
- Pooja Kulkarni (ORCID: https://orcid.org/0000-0001-9332-0721)
- Hemangi Sane (ORCID: https://orcid.org/0000-0002-4871-338X)
- Krishnaveni Kannan (ORCID: https://orcid.org/0009-0009-4563-1539)
- Alok Sharma (ORCID: https://orcid.org/0000-0002-3349-3580)
Institutions
- Neurogen Brain & Spine Institute (IN)
Publication Details
- Journal
- Clinical Transplantation and Research
- Published
- 2025-12-18
- DOI
- https://doi.org/10.4285/ctr.25.0009
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 0.00